Shenzhen Kangtai Biological Products Co., Ltd. (SHE:300601)

SHE:300601 Revenue

Shenzhen Kangtai Biological Products had revenue of 567.83M CNY in the quarter ending September 30, 2026, a decrease of -15.42%. This brings the company's total for the last twelve months to 2.45B, down -9.14% year-over-year. In the year 2025, Shenzhen Kangtai Biological Products had annual revenue of 2.67B with 0.81% growth. That makes Shenzhen Kangtai Biological Products the 13,171st largest company in the world by revenue and 2,322nd in China.

• Revenue (ttm): 2.45B
• Revenue Growth: -9.14%
• P/S Ratio: 5.83
• Revenue / Employee: 1.25M
• Employees: 1,957
• Market Cap: 14.30B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Biological Products 2.59B 97.0%
• Housing Rental 68.77M 2.6%
• Other 10.43M 0.4%

By Geography

Chart

• East China 664.45M 24.9%
• Central China 618.58M 23.1%
• South China 449.26M 16.8%
• Southwest China 346.90M 13.0%
• North China 281.96M 10.5%
• Northwest China 114.86M 4.3%
• Export 99.80M 3.7%
• Northeast China 97.27M 3.6%

Fiscal year ended Dec 31, 2025 See the full SHE:300601 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.67B	21.37M	0.81%
Dec 31, 2024	2.65B	-825.72M	-23.75%
Dec 31, 2023	3.48B	320.04M	10.14%
Jan 1, 2023	3.16B	-494.69M	-13.55%
Jan 1, 2022	3.65B	1.39B	61.51%

Data Source: S&P Global Market Intelligence Last updated: Oct 26, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 7, 2026

Data Sources Report a data error